140 related articles for article (PubMed ID: 10845017)
21. Influence of HLA-A, HLA-B, and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing.
Bartels MC; Otten HG; van Gelderen BE; Van der Lelij A
Br J Ophthalmol; 2001 Nov; 85(11):1341-6. PubMed ID: 11673303
[TBL] [Abstract][Full Text] [Related]
22. [A study of corneal transplantation and human leukocyte antigen matching].
Liu Y; Zhang R; Guan L
Zhonghua Yan Ke Za Zhi; 1996 Sep; 32(5):369-71. PubMed ID: 9590831
[TBL] [Abstract][Full Text] [Related]
23. Outcome of primary adult penetrating keratoplasty in a Saudi Arabian population.
Wagoner MD; Gonnah el-S; Al-Towerki AE;
Cornea; 2009 Sep; 28(8):882-90. PubMed ID: 19654527
[TBL] [Abstract][Full Text] [Related]
24. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
[TBL] [Abstract][Full Text] [Related]
25. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
26. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty.
Böhringer D; Reinhard T; Duquesnoy RJ; Böhringer S; Enczmann J; Lange P; Claas F; Sundmacher R
Transplantation; 2004 Feb; 77(3):417-21. PubMed ID: 14966417
[TBL] [Abstract][Full Text] [Related]
28. Validation of tissue quality parameters for donor corneas, designated for emergency cases: corneal graft survival.
Rijneveld WJ; Wolff R; Völker-Dieben HJ; Pels E
Acta Ophthalmol; 2011 Dec; 89(8):734-40. PubMed ID: 20039852
[TBL] [Abstract][Full Text] [Related]
29. Thiol redox and immune regulation in corneal transplantation.
Yamada J
Cornea; 2005 Nov; 24(8 Suppl):S59-S65. PubMed ID: 16227826
[TBL] [Abstract][Full Text] [Related]
30. Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation.
Sanfilippo F; MacQueen JM; Vaughn WK; Foulks GN
N Engl J Med; 1986 Jul; 315(1):29-35. PubMed ID: 3520323
[TBL] [Abstract][Full Text] [Related]
31. [Chronic endothelial cell loss of the graft after penetrating keratoplasty: influence of endothelial cell migration from graft to host].
Reinhard T; Böhringer D; Hüschen D; Sundmacher R
Klin Monbl Augenheilkd; 2002 Jun; 219(6):410-6. PubMed ID: 12136435
[TBL] [Abstract][Full Text] [Related]
32. Third or greater penetrating keratoplasties: indications, survival, and visual outcomes.
Yildiz EH; Hoskins E; Fram N; Rapuano CJ; Hammersmith KM; Laibson PR; Cohen EJ
Cornea; 2010 Mar; 29(3):254-9. PubMed ID: 20118784
[TBL] [Abstract][Full Text] [Related]
33. Donor source affects the outcome of ocular surface reconstruction in chemical or thermal burns of the cornea.
Shimazaki J; Shimmura S; Tsubota K
Ophthalmology; 2004 Jan; 111(1):38-44. PubMed ID: 14711712
[TBL] [Abstract][Full Text] [Related]
34. The Australian Corneal Graft Registry. 1990 to 1992 report.
Aust N Z J Ophthalmol; 1993 May; 21(2 Suppl):1-48. PubMed ID: 8333942
[TBL] [Abstract][Full Text] [Related]
35. A 10-year review of penetrating keratoplasty.
Inoue K; Amano S; Oshika T; Sawa M; Tsuru T
Jpn J Ophthalmol; 2000; 44(2):139-45. PubMed ID: 10715380
[TBL] [Abstract][Full Text] [Related]
36. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection.
Khaireddin R; Wachtlin J; Hopfenmüller W; Hoffmann F
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1020-8. PubMed ID: 14673570
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes.
Javadi MA; Feizi S; Karbasian A; Rastegarpour A
Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study on the endothelial immune rejection after penetrating keratoplasty].
Shi WY; Wang X; Xie LX
Zhonghua Yan Ke Za Zhi; 2005 Feb; 41(2):145-9. PubMed ID: 15840342
[TBL] [Abstract][Full Text] [Related]
39. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for corneal graft failure and rejection in penetrating keratoplasty.
Inoue K; Amano S; Oshika T; Tsuru T
Acta Ophthalmol Scand; 2001 Jun; 79(3):251-5. PubMed ID: 11401633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
